Stellar Biotechnologies Inc (SBOT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Stellar Biotechnologies Inc (SBOT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7891
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Stellar Biotechnologies Inc (Stellar Bio), formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immune-stimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injectable product to assess immune response. Its products comprise Stellar KLH protein which can be used in various grades, formulations, and configurations for both clinical and research applications and KLH Elisa Kits. Stellar Bio’s products are used in immunotherapies as an immune stimulant in immunotoxicology applications and therapeutic vaccine conjugation. The company partners with research centers and developers of active immunotherapies and therapeutic vaccines. Stellar Bio is headquartered in Port Hueneme, California, the US.

Stellar Biotechnologies Inc (SBOT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Stellar Biotechnologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Stellar Biotechnologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Stellar Biotechnologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Stellar Biotechnologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Stellar Biotechnologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Stellar Biotechnologies Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Stellar Biotech to Raise USD3 Million in Private Placement of Shares up on Exercise of Warrants 10
Stellar Biotech Raises USD5.5 Million in Public Offering of Units 11
Stellar Biotechnologies Completes Second Tranche Private Placement Of Units For US$12 Million 12
Stellar Biotechnologies Completes Second Tranche Of Private Placement Of Units For US$5 Million 14
Stellar Biotechnologies Completes Private Placement Of Units For US$1.6 Million 16
Stellar Biotechnologies Inc – Key Competitors 17
Stellar Biotechnologies Inc – Key Employees 18
Stellar Biotechnologies Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 19
Recent Developments 20
Financial Announcements 20
Aug 08, 2018: Stellar Biotechnologies reports third quarter financial results 20
May 07, 2018: Stellar Biotechnologies Announces Second Quarter Financial Results 22
Feb 07, 2018: Stellar Biotechnologies Reports First Quarter 2018 Financial Results 24
Dec 01, 2017: Stellar Biotechnologies Reports Fiscal Year 2017 Financial Results 25
May 09, 2017: Stellar Biotechnologies Reports Second Quarter 2017 Financial Results 26
Feb 06, 2017: Stellar Biotechnologies Reports First Quarter 2017 Financial Results 28
Corporate Communications 29
Feb 27, 2018: Stellar Biotechnologies Appoints Bioprocess Expert to Lead Manufacturing 29
Jan 25, 2018: Stellar Biotechnologies Appoints Pharma Licensing Expert to Board of Directors 30
Jun 07, 2017: Stellar Biotechnologies Expands Operations Team 31
Other Significant Developments 32
Mar 06, 2017: The Life Sciences Report Examines Stellar Biotechnologies Inking Multiyear KLH Supply Agreement with Amaran Biotechnology; Stellar Up 27% on News 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Stellar Biotechnologies Inc, Medical Equipment, Key Facts, 2017 2
Stellar Biotechnologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Stellar Biotechnologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Stellar Biotechnologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Stellar Biotechnologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Stellar Biotechnologies Inc, Deals By Market, 2012 to YTD 2018 8
Stellar Biotechnologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Stellar Biotech to Raise USD3 Million in Private Placement of Shares up on Exercise of Warrants 10
Stellar Biotech Raises USD5.5 Million in Public Offering of Units 11
Stellar Biotechnologies Completes Second Tranche Private Placement Of Units For US$12 Million 12
Stellar Biotechnologies Completes Second Tranche Of Private Placement Of Units For US$5 Million 14
Stellar Biotechnologies Completes Private Placement Of Units For US$1.6 Million 16
Stellar Biotechnologies Inc, Key Competitors 17
Stellar Biotechnologies Inc, Key Employees 18
Stellar Biotechnologies Inc, Subsidiaries 19
Stellar Biotechnologies Inc, Joint Venture 19

List of Figures
Stellar Biotechnologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Stellar Biotechnologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Stellar Biotechnologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Stellar Biotechnologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Stellar Biotechnologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Stellar Biotechnologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Stellar Biotechnologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Stellar Biotechnologies Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Stellar Biotechnologies Inc (SBOT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Neste Engineering Solutions Oy:企業の戦略的SWOT分析
    Neste Engineering Solutions Oy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • TE Connectivity Ltd (TEL):企業の財務・戦略的SWOT分析
    TE Connectivity Ltd (TEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Xtant Medical Holdings Inc (XTNT)-製薬・医療分野:企業M&A・提携分析
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings, Inc. is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteow …
  • Selventa Inc-製薬・医療分野:企業M&A・提携分析
    Summary Selventa Inc (Selventa), formerly Genstruct Inc is a healthcare technology services provider that operates life science consulting projects. The company offers system diagnostic development services that identifies molecular mechanisms, networks and biomarkers to develop therapeutics, molecu …
  • Trafigura Group Pte. Ltd.-石油・ガス分野:企業M&A・提携分析
    Summary Trafigura Group Pte. Ltd. (Trafigura), a subsidiary of Trafigura Beheer B.V., is an independent commodity trading and logistics company. Its operations include trading of physical commodities, shipping and chartering, and asset management. The company sources, stores, transports and delivers …
  • Egdon Resources Plc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Egdon Resources Plc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Egdon Resources Plc (Egdon) is oil and gas company that offers exploration and production services. The company explores and develops petroleum and natural gas assets in East Midlands, North East Eng …
  • IsoRay Inc (ISR):医療機器:M&Aディール及び事業提携情報
    Summary IsoRay Inc (IsoRay), formerly Century Park Pictures Corporation, is a medical technology company which develops, manufactures and markets isotope-based personalized brachytherapy products and devices for the treatment of cancer and other malignant tumors. The company produced Cesium-131, a r …
  • Eolus Vind AB (EOLU B):企業の財務・戦略的SWOT分析
    Summary Eolus Vind AB (Eolus Vind) is a wind farm developer that offers construction, development, and operation of green field projects and wind power plants. The company provides services such as consultancy services, administration, financing, development, and management of wind farms. It also of …
  • System Dynamics International Incorporated:企業の戦略・SWOT・財務分析
    System Dynamics International Incorporated - Strategy, SWOT and Corporate Finance Report Summary System Dynamics International Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Svenska Cellulosa Aktiebolaget:企業の戦略・SWOT・財務情報
    Svenska Cellulosa Aktiebolaget - Strategy, SWOT and Corporate Finance Report Summary Svenska Cellulosa Aktiebolaget - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Imugene Ltd (IMU):製薬・医療:M&Aディール及び事業提携情報
    Summary Imugene Ltd (Imugene) is a clinical stage biopharmaceutical company which researches and develops vaccines in the area of immune-oncology. The company focuses on developing immunotherapies for the treatment of HER-2+ gastric and breast cancer. The HER-2 receptor works on surface of various t …
  • Beijing Beilu Pharmaceutical Co Ltd (300016):製薬・医療:M&Aディール及び事業提携情報
    Summary Beijing Beilu Pharmaceutical Co Ltd (Beijing BeiLu) is a manufacturer of traditional Chinese medicine preparation and psychiatric products. The company provides product portfolio such as contrast media products, anti anxiety medicines and oral antihyperglycemic agents, among others. Its cont …
  • VentriPoint Diagnostics Ltd-医療機器分野:企業M&A・提携分析
    Summary VentriPoint Diagnostics Ltd (Ventripoint) is a medical device company that manufactures and distributes diagnostic tools and monitoring devices for patients with heart diseases. The company offers ventripoint diagnostic system, which is a cardiovascular monitoring and measurement device. Its …
  • Superior Energy Services Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Superior Energy Services Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Superior Energy Services Inc (Superior Energy) is a provider of equipment and production services to the energy industry. It offers drilling, completion and production-related services to in …
  • Aeras Global TB Vaccine Foundation Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Aeras Global TB Vaccine Foundation Inc (Aeras) is a non-profit biotech organization that develops tuberculosis (TB) vaccines. The organization offers TB vaccine candidates, preclinical candidates and vaccine candidates. Its services include portfolio management, preclinical research, clinica …
  • C. R. Bard Inc (BCR)-医療機器分野:企業M&A・提携分析
    Summary C. R. Bard Inc (Bard) is a medical device company, which offers medical, surgical, diagnostic and patient care devices related to vascular disorders, urology disorders, cancer diagnosis and treatment and surgical specialties. Its major products include devices for the treatment of peripheral …
  • SMART Medical Systems Ltd-医療機器分野:企業M&A・提携分析
    Summary Smart Medical Systems Ltd (Smart) is a medical device company that develops and manufactures medical equipment in the field of gastroenterology and GI endoscopy. The company offers products such as inflation systems, platform, naviaid ABC, G-eye, naviaid AB, future naviaid products, controll …
  • Hammond Power Solutions Inc (HPS.A):企業の財務・戦略的SWOT分析
    Hammond Power Solutions Inc (HPS.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • The Emirates Group:企業の戦略・SWOT・財務情報
    The Emirates Group - Strategy, SWOT and Corporate Finance Report Summary The Emirates Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Aristocrat Leisure Ltd (ALL):企業の財務・戦略的SWOT分析
    Aristocrat Leisure Ltd (ALL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆